Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2019 Nov 5;38:451. doi: 10.1186/s13046-019-1441-3

Correction to: Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer

Yuyuan Yao 1,#, Qinglong Guo 1,#, Yue Cao 1, Yangmin Qiu 1, Renxiang Tan 2, Zhou Yu 1, Yuxin Zhou 1, Na Lu 1,
PMCID: PMC6829918  PMID: 31690336

Correction to: J Exp Clin Cancer Res (2018) 37: 282

https://doi.org/10.1186/s13046-018-0960-7

In the original publication of this article [1], Fig. 3 is wrong, but does not affect discussions and conclusions drawn in the article.

The corrected Fig. 3 is shown below:

Fig. 3.

Fig. 3

.

Reference

  • 1.Yao Y, et al. Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer. J Exp Clin Cancer Res. 2018;37:282. doi: 10.1186/s13046-018-0960-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES